Works matching Isoniazid


Results: 5000
    1
    2

    Quantification of pyrazinamide, isoniazid, acetyl‐isoniazid, and rifampicin by a high‐performance liquid chromatography method in human plasma from patients with tuberculosis.

    Published in:
    Journal of Separation Science, 2021, v. 44, n. 2, p. 521, doi. 10.1002/jssc.202000672
    By:
    • Hernández‐González, Oswaldo;
    • Zarazúa, Sergio;
    • Veytia‐Bucheli, José Ignacio;
    • González‐Chávez, Marco Martín;
    • Rodríguez‐Pinal, Cristian Jazmín;
    • Medellín‐Garibay, Susanna Edith;
    • Uresti‐Rivera, Edith Elena;
    • Pérez‐Vázquez, Francisco Javier;
    • Portales‐Pérez, Diana Patricia;
    • Romano‐Moreno, Silvia;
    • Milán‐Segovia, Rosa del Carmen
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 3, p. 343, doi. 10.1164/rccm.202311-2004OC
    By:
    • Gausi, Kamunkhwala;
    • Ignatius, Elisa H.;
    • De Jager, Veronique;
    • Upton, Caryn;
    • Kim, Soyeon;
    • McKhann, Ashley;
    • Moran, Laura;
    • Wiesner, Lubbe;
    • von Groote-Bidlingmaier, Florian;
    • Marzinek, Philip;
    • Vanker, Naadira;
    • Yvetot, Joseph;
    • Pierre, Samuel;
    • Rosenkranz, Susan L.;
    • Swindells, Susan;
    • Diacon, Andreas H.;
    • Nuermberger, Eric L.;
    • Denti, Paolo;
    • Dooley, Kelly E.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16

    Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models.

    Published in:
    European Journal of Clinical Pharmacology, 2022, v. 78, n. 10, p. 1535, doi. 10.1007/s00228-022-03362-7
    By:
    • Thomas, Levin;
    • Raju, Arun Prasath;
    • Chaithra;
    • M, Sonal Sekhar;
    • Varma, Muralidhar;
    • Saravu, Kavitha;
    • Banerjee, Mithu;
    • SV, Chidananda Sanju;
    • Mallayasamy, Surulivelrajan;
    • Rao, Mahadev
    Publication type:
    Article
    17

    NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy.

    Published in:
    European Journal of Clinical Pharmacology, 2013, v. 69, n. 5, p. 1091, doi. 10.1007/s00228-012-1429-9
    By:
    • Azuma, Junichi;
    • Ohno, Masako;
    • Kubota, Ryuji;
    • Yokota, Soichiro;
    • Nagai, Takayuki;
    • Tsuyuguchi, Kazunari;
    • Okuda, Yasuhisa;
    • Takashima, Tetsuya;
    • Kamimura, Sayaka;
    • Fujio, Yasushi;
    • Kawase, Ichiro
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25

    Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age.

    Published in:
    Antibiotics (2079-6382), 2023, v. 12, n. 2, p. 272, doi. 10.3390/antibiotics12020272
    By:
    • López-Ramos, Maria Goretti;
    • Vinent, Joan;
    • Aarnoutse, Rob;
    • Colbers, Angela;
    • Velasco-Arnaiz, Eneritz;
    • Martorell, Loreto;
    • Falcón-Neyra, Lola;
    • Neth, Olaf;
    • Prieto, Luis;
    • Guillén, Sara;
    • Baquero-Artigao, Fernando;
    • Méndez-Echevarría, Ana;
    • Gómez-Pastrana, David;
    • Jiménez, Ana Belén;
    • Lahoz, Rebeca;
    • Ramos-Amador, José Tomás;
    • Soriano-Arandes, Antoni;
    • Santiago, Begoña;
    • Farré, Rosa;
    • Fortuny, Clàudia
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50